Where exactly does the 99.9% inhibition value come from? Is there a primary in vitro study testing acridones specifically against OROV that reports this number? If so, why is it not cited directly instead of a 2024 review?
Did you verify whether Saivish et al. (2024) actually presents original experimental data for this claim, or does it itself cite an earlier study?
If the latter, why was the primary source omitted?
Given that acridones’ mechanism is discussed alongside binding to HSV-1 endonuclease, is it possible this efficacy figure was originally from a different virus and inappropriately generalized to OROV?